<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03478254</url>
  </required_header>
  <id_info>
    <org_study_id>C-127</org_study_id>
    <nct_id>NCT03478254</nct_id>
  </id_info>
  <brief_title>Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).</brief_title>
  <acronym>AVADI-1</acronym>
  <official_title>Adherence to Guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in Adult Patients With Type 1 Diabetes Mellitus (AVADI-1).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jesús Moreno Fernández</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Castilla-La Mancha Health Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Castilla-La Mancha Health Service</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study about adherence to guidelines for Influenza, Pneumococcal and Hepatitis B&#xD;
      Vaccination in adult patients with type 1 Diabetes mellitus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cross-sectional analysis about adherence to guidelines for Influenza, Pneumococcal and&#xD;
      Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.&#xD;
&#xD;
      All clinical variables are gathered from two EMR softwares (Mambrino XXI and Turriano).&#xD;
&#xD;
      Data analysis is conducted using SPSS (Chicago, IL) statistics software. Results are&#xD;
      presented as mean ± SD values or percentages. A paired Student's t-test or a Wilcoxon&#xD;
      signed-rank test were used for the analysis of differences. Comparisons between proportions&#xD;
      were analyzed using a chi-squared test. A P value &lt; 0.05 was considered statistically&#xD;
      significant.&#xD;
&#xD;
      The protocol was approved by the reference Castilla-La Mancha Public Health Institute Ethic&#xD;
      Committee. All participants provided written informed consent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to Regional Guidelines for the Immunization of Adults With Type 1 Diabetes Mellitus (T1DM</measure>
    <time_frame>1 year</time_frame>
    <description>Adherence to Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Age According to Vaccination Status</measure>
    <time_frame>1 year</time_frame>
    <description>Age (years)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Have Taken Related Sick Leaves</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients who have taken related sick leaves.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Vaccination adherence</arm_group_label>
    <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza Vaccination status, Pneumococcal Vaccination status and Hepatitis B Virus (HBV) status.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza vaccination</intervention_name>
    <description>Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.</description>
    <arm_group_label>Vaccination adherence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Pneumococcal vaccination</intervention_name>
    <description>Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.</description>
    <arm_group_label>Vaccination adherence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Hepatitis B Virus (HBV) vaccination</intervention_name>
    <description>Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
    <arm_group_label>Vaccination adherence</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients attended to care in consults during this period were eligible for chart&#xD;
        review. Patients included in the analysis were required to be ≥18 years of age and be&#xD;
        diagnosed of type 1 diabetes mellitus.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥18 years of age.&#xD;
&#xD;
          -  Diagnosed of Type 1 Diabetes Mellitus.&#xD;
&#xD;
          -  Be attended in Ciudad Real General University Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 18 years old.&#xD;
&#xD;
          -  Other types of diabetes mellitus.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena M Ortega Rodrigo</last_name>
    <role>Study Chair</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Alberto Garcia Seco, RN</last_name>
    <role>Study Chair</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Garcia Seco</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad de Córdoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angela M Seco Segura, RN</last_name>
    <role>Study Chair</role>
    <affiliation>Castilla-La Mancha Health Service</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obispo Rafael Torija, St.</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003 Feb;26(2):510-3.</citation>
    <PMID>12547890</PMID>
  </reference>
  <reference>
    <citation>Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005 Aug 1;41(3):281-8. Epub 2005 Jun 16.</citation>
    <PMID>16007521</PMID>
  </reference>
  <reference>
    <citation>Alcusky MJ, Pawasauskas J. Adherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes. Clin Diabetes. 2015 Jul;33(3):116-22. doi: 10.2337/diaclin.33.3.116.</citation>
    <PMID>26203204</PMID>
  </reference>
  <reference>
    <citation>Sastre J, Pinés PJ, Moreno J, Aguirre M, Blanco B, Calderón D, Herranz S, Roa C, Lopez J; Grupo de estudio DIACAM 1. Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study. Endocrinol Nutr. 2012 Nov;59(9):539-46. doi: 10.1016/j.endonu.2012.07.003. Epub 2012 Oct 4. English, Spanish.</citation>
    <PMID>23039989</PMID>
  </reference>
  <reference>
    <citation>American Association of Diabetes Educators. Vaccination practices for hepatitis B, influenza, and pneumococcal disease for people with diabetes. Diabetes Educ. 2014 Jan-Feb;40(1):122-4. doi: 10.1177/0145721713513545.</citation>
    <PMID>24442103</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>March 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <results_first_submitted>October 27, 2019</results_first_submitted>
  <results_first_submitted_qc>December 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 11, 2021</results_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Castilla-La Mancha Health Service</investigator_affiliation>
    <investigator_full_name>Jesús Moreno Fernández</investigator_full_name>
    <investigator_title>Endocrinology and Nutrition Service, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>In request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year.</ipd_time_frame>
    <ipd_access_criteria>Related investigation.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT03478254/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT03478254/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT03478254/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Influenza Vaccination</title>
          <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza, Pneumococcal and HBV Vaccination status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
HBV vaccination: Correct HBV vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="300"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="300"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>White caucasian &gt;18 yrs type 1 diabetes mellitus patients</population>
      <group_list>
        <group group_id="B1">
          <title>Adherence Vaccination</title>
          <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza, pneumococcal and HBV vaccination status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
HBV vaccination: Correct HBV vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="300"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="280"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Adherence to Regional Guidelines for the Immunization of Adults With Type 1 Diabetes Mellitus (T1DM</title>
        <description>Adherence to Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adherece Vaccination</title>
            <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza, Pneumococcal and HBV Vaccination status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
HBV vaccination: Correct HBV vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
          </group>
        </group_list>
        <measure>
          <title>Adherence to Regional Guidelines for the Immunization of Adults With Type 1 Diabetes Mellitus (T1DM</title>
          <description>Adherence to Influenza, Pneumococcal and Hepatitis B Vaccination in adult patients with type 1 Diabetes mellitus.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="300"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>influenza vaccination</title>
                  <measurement_list>
                    <measurement group_id="O1" value="165"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Pneumoccocal vaccination</title>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HBV vaccination</title>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No vaccination</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Age According to Vaccination Status</title>
        <description>Age (years)</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Adherece Vaccination</title>
            <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza, Pneumococcal and HBV Vaccination status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
HBV vaccination: Correct HBV vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Age According to Vaccination Status</title>
          <description>Age (years)</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="300"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Age : Influenzae vaccination:</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.5" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age : No influcenzae vaccination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.7" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age : HBV vaccination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.3" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age : HBV pneumoccocal vaccination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.5" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Have Taken Related Sick Leaves</title>
        <description>Number of patients who have taken related sick leaves.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vaccination Adherence</title>
            <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza Vaccination status, Pneumococcal Vaccination status and Hepatitis B Virus (HBV) status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
Hepatitis B Virus (HBV) vaccination: Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Have Taken Related Sick Leaves</title>
          <description>Number of patients who have taken related sick leaves.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="300"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Events were not collected</time_frame>
      <desc>Adverse Events were not collected</desc>
      <group_list>
        <group group_id="E1">
          <title>Adherence Vaccination</title>
          <description>All type 1 diabetes adults patients attended in Ciudad Real General University Hospital willl be checked for Influenza, Pneumococcal and HBV Vaccination status.&#xD;
Influenza vaccination: Correct influenza vaccination status was considered in the following situation:&#xD;
- Received at least one Influenza vaccine dose in the last year.&#xD;
Pneumococcal vaccination: Correct pneumococal vaccination status was considered if a subject received at least one of the following options:&#xD;
One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.&#xD;
One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.&#xD;
One PPSV 23 dose in the last 5 years.&#xD;
One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year.&#xD;
HBV vaccination: Correct HBV vaccination status was considered in the following situation:&#xD;
.- Received at least three consecutive doses of HBV vaccine during six consecutive months.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Angela M. Seco Segura RN, Endocrinology and Nutrition Department.</name_or_title>
      <organization>Ciudad Real University Hospital. Castilla La Mancha Health Service.</organization>
      <phone>926278000 ext 79510</phone>
      <email>amsese@live.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

